Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

NEO

+ Watchlist+ Portfolio

NeoGenomics, Inc.

Regulated industrySells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$15.25
52-Week Range
$7.07 – $20.15
Market Cap
$1.98B
P/E (TTM)
—
EPS (TTM)
-0.24
Dividend Yield
0.00%
Advanced Metrics
Price/Book
2.47
PEG Ratio
2.09
Return on Equity
-3.94%
Return on Assets
-1.96%
Gross Margin
44.77%
Operating Margin
-5.47%
Profit Margin
-4.10%
Current Ratio
3.53
Debt/Equity
0.56
Total Debt
$449.14M
Free Cash Flow
$4.80M
Revenue Growth
11.40%
Earnings Growth
—
Enterprise Value
$2.29B

Market Snapshot

About

NeoGenomics, Inc. provides cancer-focused genetic testing and diagnostics services. The company offers molecular and cytogenetic testing, pathology services, and clinical trials support to oncologists, hospitals, and pharmaceutical clients.